Moderna's CEO Calls These 3 Elements "Critical" for Vaccine Success
Moderna (NASDAQ: MRNA) has been among the first to address the biggest challenge facing coronavirus vaccines right now: new variants of concern. These strains put the effectiveness of current vaccines -- including Moderna's -- in jeopardy. And variants are gaining ground worldwide. Moderna recently said it's exploring three ways of handling the problem: an additional dose of the current vaccine; a strain-specific booster; and a shot that combines Moderna's authorized vaccine with a strain-specific booster.
Rivals have launched similar efforts. But according to Moderna CEO Stephane Bancel, three things set Moderna apart from others in this race to handle an evolving virus. Here's what he had to say during the company's recent earnings call.
Image source: Getty Images.
Source Fool.com
